From the Journals

ASCO addresses financial barriers to cancer clinical trials


 

FROM JOURNAL OF CLINICAL ONCOLOGY

The American Society of Clinical Oncology (ASCO) has released a policy statement addressing financial barriers that may prevent cancer patients from participating in clinical trials.

The four main recommendations in ASCO’s policy statement are:

  • Payers should create clear, consistent, streamlined, and transparent policies regarding clinical trial coverage.
  • Patients should receive easy-to-understand information about potential out-of-pocket costs.
  • “Ethically appropriate” financial compensation for out-of-pocket costs should be allowed.
  • Researchers should be incentivized to investigate and “better characterize” costs incurred by cancer patients in clinical trials as well as identify ways to “mitigate the risk of trial-associated financial hardship.”

ASCO’s full policy statement, “Addressing Financial Barriers to Patient Participation in Clinical Trials,” is available on the Journal of Clinical Oncology website.

SOURCE: Winkfield KM et al. J Clin Oncol. 2018 Sep 13:JCO1801132. doi: 10.1200/JCO.18.01132.

Recommended Reading

Physician groups call for CMS to drop E/M proposal
MDedge Hematology and Oncology
How to bridge the gap for rural cancer patients
MDedge Hematology and Oncology
Cancer researchers fall short on financial disclosures
MDedge Hematology and Oncology
Penalties not necessary to save money in some Medicare ACOs
MDedge Hematology and Oncology
England green-lights coverage of one CAR T-cell therapy
MDedge Hematology and Oncology
AACR: New cancer cases predicted to rise above 2.3 million by 2035
MDedge Hematology and Oncology
Burnout may jeopardize patient care
MDedge Hematology and Oncology
E/M comments may fall on deaf ears at CMS
MDedge Hematology and Oncology
Disruptive physicians: Is this an HR or MEC issue?
MDedge Hematology and Oncology
Kymriah cost effectiveness depends on long-term outcomes
MDedge Hematology and Oncology